You have mentioned this a few times now , Pharma news of Orphan Designation of midkine antibody would be great but it could be a very long time away .
Midkine related studies have moved extremely slowly , which is a major reason behind the disappointing sp.
Ann: Preliminary Final Report, page-134
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable